These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 7462698)

  • 21. Effect of intravenously injected killed pneumococci on leukocytes, complement, and phagocytosis in rabbits.
    Reed WP; Jaffee P; Albright EL; Williams RC
    Infect Immun; 1980 Sep; 29(3):1021-7. PubMed ID: 7429626
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of complement in Streptococcus pneumoniae-associated haemolytic uraemic syndrome.
    Szilágyi A; Kiss N; Bereczki C; Tálosi G; Rácz K; Túri S; Györke Z; Simon E; Horváth E; Kelen K; Reusz GS; Szabó AJ; Tulassay T; Prohászka Z
    Nephrol Dial Transplant; 2013 Sep; 28(9):2237-45. PubMed ID: 23787556
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of complement in the host's defense against Haemophilus influenzae.
    Winkelstein JA; Moxon ER
    J Infect Dis; 1992 Jun; 165 Suppl 1():S62-5. PubMed ID: 1588179
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of the property of C-reactive protein to activate the classical pathway of complement in protecting mice from pneumococcal infection.
    Suresh MV; Singh SK; Ferguson DA; Agrawal A
    J Immunol; 2006 Apr; 176(7):4369-74. PubMed ID: 16547275
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pneumococcal intracellular killing is abolished by polysaccharide despite serum complement activity.
    Schweinle JE
    Infect Immun; 1986 Dec; 54(3):876-81. PubMed ID: 3781629
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biofilm formation avoids complement immunity and phagocytosis of Streptococcus pneumoniae.
    Domenech M; Ramos-Sevillano E; García E; Moscoso M; Yuste J
    Infect Immun; 2013 Jul; 81(7):2606-15. PubMed ID: 23649097
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The requirement of specific anticapsular IgG for killing of Haemophilus influenzae by the alternative pathway of complement activation.
    Tarr PI; Hosea SW; Brown EJ; Schneerson R; Sutton A; Frank MM
    J Immunol; 1982 Apr; 128(4):1772-5. PubMed ID: 6977569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Essential role of factor B of the alternative complement pathway in complement activation and opsonophagocytosis during acute pneumococcal otitis media in mice.
    Li Q; Li YX; Stahl GL; Thurman JM; He Y; Tong HH
    Infect Immun; 2011 Jul; 79(7):2578-85. PubMed ID: 21502587
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of complement in C-reactive-protein-mediated protection of mice from Streptococcus pneumoniae.
    Szalai AJ; Briles DE; Volanakis JE
    Infect Immun; 1996 Nov; 64(11):4850-3. PubMed ID: 8890251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of complement in viral infections. III. Activation of the classical and alternative complement pathways by Sindbis virus.
    Hirsch RL; Winkelstein JA; Griffin DE
    J Immunol; 1980 May; 124(5):2507-10. PubMed ID: 7365263
    [No Abstract]   [Full Text] [Related]  

  • 31. Alternative Pathway Inhibition by Exogenous Factor H Fails to Attenuate Inflammation and Vascular Leakage in Experimental Pneumococcal Sepsis in Mice.
    van der Maten E; van Selm S; Langereis JD; Bootsma HJ; van Opzeeland FJ; de Groot R; de Jonge MI; van der Flier M
    PLoS One; 2016; 11(2):e0149307. PubMed ID: 26872035
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early clearance of pneumococci from the lungs of decomplemented rats.
    Rehm SR; Coonrod JD
    Infect Immun; 1982 Apr; 36(1):24-9. PubMed ID: 7076296
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of peptidoglycan from Staphylococcus aureus in leukopenia, thrombocytopenia, and complement activation associated with bacteremia.
    Spika JS; Peterson PK; Wilkinson BJ; Hammerschmidt DE; Verbrugh HA; Verhoef J; Quie PG
    J Infect Dis; 1982 Aug; 146(2):227-34. PubMed ID: 7108273
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationships between alternative complement pathway activation, C-reactive protein, and pneumococcal infection.
    Rabinovitch RA; Koethe SM; Kalbfleisch JH; Preheim LC; Rytel MW
    J Clin Microbiol; 1986 Jan; 23(1):56-61. PubMed ID: 3700607
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inherited deficiency of properdin and C2 in a patient with recurrent bacteremia.
    Gelfand EW; Rao CP; Minta JO; Ham T; Purkall DB; Ruddy S
    Am J Med; 1987 Mar; 82(3 Spec No):671-5. PubMed ID: 3826129
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of complement receptors 1 and 2 (CD35 and CD21), C3, C4, and C5 in survival by mice of Staphylococcus aureus bacteremia.
    Cunnion KM; Benjamin DK; Hester CG; Frank MM
    J Lab Clin Med; 2004 Jun; 143(6):358-65. PubMed ID: 15192652
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of opsonins in recovery from experimental pneumococcal pneumonia.
    Guckian JC; Christensen GD; Fine DP
    J Infect Dis; 1980 Aug; 142(2):175-90. PubMed ID: 6997403
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blood clearance by anti-phosphocholine antibodies as a mechanism of protection in experimental pneumococcal bacteremia.
    McDaniel LS; Benjamin WH; Forman C; Briles DE
    J Immunol; 1984 Dec; 133(6):3308-12. PubMed ID: 6491288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complement C1q and C3 are critical for the innate immune response to Streptococcus pneumoniae in the central nervous system.
    Rupprecht TA; Angele B; Klein M; Heesemann J; Pfister HW; Botto M; Koedel U
    J Immunol; 2007 Feb; 178(3):1861-9. PubMed ID: 17237437
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pneumolysin, PspA, and PspC contribute to pneumococcal evasion of early innate immune responses during bacteremia in mice.
    Quin LR; Moore QC; McDaniel LS
    Infect Immun; 2007 Apr; 75(4):2067-70. PubMed ID: 17220305
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.